Equity Capital And Reserves Cambiamento Data
Adcock Ingram Holdings ZAR 5.48B 87.97M 2023-12
Celltrion KRW 374.61B 16.61T 2024-03
Clinuvel Pharmaceuticals AUD 178.65M 14.02M 2023-12
Cochlear AUD 1.78B 33M 2023-12
CSL USD 17.18B 1.39B 2023-12
Cspc Pharmaceutical CNY 35.02B 3.2B 2023-12
Dianthus Therapeutics USD 372.69M 203.82M 2024-03
Ecofibre AUD 30.63M 44M 2023-12
Kangmei Pharma CNY 7.09B 288.52M 2024-03
Knight Therapeutics CAD 761.89M 15.02M 2024-03
Laboratorios Farma EUR 523.78M 15.6M 2024-03
Malin Corporation EUR 109.5M 13.3M 2023-12
Mayne Pharma AUD 634.36M 163.83M 2023-06
Medical Developments International AUD 75.69M 5.62M 2023-12
Nanosonics AUD 175.54M 11.68M 2023-12
Neuren Pharmaceuticals AUD 205.21M 113.69M 2023-12
Opthea USD -46913720 41.06M 2023-12
Organigram Holdings CAD 271.8M 13.97M 2024-03
Pacific Edge NZD 68.3M 20.11M 2023-09
Paradigm Biopharmaceuticals AUD 33.8M 19.88M 2023-12
Pharma Mar EUR 192.67M 764K 2024-03
Polynovo AUD 69.05M 3.67M 2023-12
Probiotec AUD 88.33M 1.19M 2023-12
PYC Therapeutics AUD 29.9M 2.15M 2023-12
Qiagen NV USD 3.6B 208.14M 2024-03
Ramsay Health Care AUD 4.83B 679.3M 2023-12
ResMed USD 4.63B 148.07M 2024-03
Sartorius EUR 3.76B 1.69B 2024-03
Sino Biopharmaceutical CNY 30.47B 485.17M 2023-12
Telix Pharmaceuticals AUD 148.91M 72.85M 2023-12
Tilray USD 3.34B 25.3M 2024-02
Zz Pientze Pharmaceu 13.01B 877.71M 2023-09



Avita Medical Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2024.